Literature DB >> 21807825

Who is paying the price? Loss of health insurance coverage early in psychosis.

Tyler J Dodds1, Vivek H Phutane, B Jamie Stevens, Scott W Woods, Michael J Sernyak, Vinod H Srihari.   

Abstract

OBJECTIVE: Discontinuities in health insurance coverage may make it difficult for individuals early in psychosis to receive the services that are critical in determining long-term outcome. This study reports on the rates and continuity of insurance coverage among a cohort of early-psychosis patients enrolled in Specialized Treatment Early in Psychosis (STEP) at the Connecticut Mental Health Center.
METHODS: Insurance status at baseline, six months, and 12 months was collected from 82 participants from a combination of self-reports, clinical chart review, clinician reports, and a database maintained by the state Department of Social Services.
RESULTS: A total of 34 participants did not know whether they had health insurance or did not appear for follow-up assessments at six and 12 months. Among the remaining 48 participants, at baseline 18 had private insurance, 13 had public insurance, and 16 had no insurance. By the 12-month assessment, 13 (72%) privately insured and five (38%) publicly insured participants had lost coverage; less than one-third of the 48 participants (N=14) maintained continuous coverage.
CONCLUSIONS: Specialty services for individuals experiencing early psychosis should address the difficulty of maintaining health insurance coverage during a period of illness in which continuity of care is critical to recovery.

Entities:  

Mesh:

Year:  2011        PMID: 21807825      PMCID: PMC4469900          DOI: 10.1176/ps.62.8.pss6208_0878

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  16 in total

1.  Will health insurance reform in the United States help people with schizophrenia?

Authors:  Howard H Goldman
Journal:  Schizophr Bull       Date:  2010-07-21       Impact factor: 9.306

2.  The war isn't over.

Authors:  Henry J Aaron; Robert D Reischauer
Journal:  N Engl J Med       Date:  2010-03-24       Impact factor: 91.245

Review 3.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

4.  Early detection of first-episode psychosis: the effect on 1-year outcome.

Authors:  Tor K Larsen; Ingrid Melle; Bjørn Auestad; Svein Friis; Ulrik Haahr; Jan Olav Johannessen; Stein Opjordsmoen; Bjørn Rishovd Rund; Erik Simonsen; Per Vaglum; Thomas McGlashan
Journal:  Schizophr Bull       Date:  2006-06-29       Impact factor: 9.306

5.  A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness.

Authors:  Lone Petersen; Pia Jeppesen; Anne Thorup; Maj-Britt Abel; Johan Øhlenschlaeger; Torben Østergaard Christensen; Gertrud Krarup; Per Jørgensen; Merete Nordentoft
Journal:  BMJ       Date:  2005-09-02

6.  Changes in insurance coverage and extent of care during the two years after first hospitalization for a psychotic disorder.

Authors:  J Rabinowitz; E J Bromet; J Lavelle; K J Hornak; B Rosen
Journal:  Psychiatr Serv       Date:  2001-01       Impact factor: 3.084

7.  Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.

Authors:  Robert A Rosenheck; Douglas L Leslie; Jody Sindelar; Edward A Miller; Haiqun Lin; T Scott Stroup; Joseph McEvoy; Sonia M Davis; Richard S E Keefe; Marvin Swartz; Diana O Perkins; John K Hsiao; Jeffrey Lieberman
Journal:  Am J Psychiatry       Date:  2006-12       Impact factor: 18.112

8.  Health services determinants of the duration of untreated psychosis among African-American first-episode patients.

Authors:  Michael T Compton; Claire E Ramsay; Ruth S Shim; Sandra M Goulding; Tynessa L Gordon; Paul S Weiss; Benjamin G Druss
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

9.  Relationship between type of insurance and care during the early course of psychosis.

Authors:  J Rabinowitz; E J Bromet; J Lavelle; K J Severance; S L Zariello; B Rosen
Journal:  Am J Psychiatry       Date:  1998-10       Impact factor: 18.112

10.  Correlates of health insurance among persons with schizophrenia in a statewide behavioral health care system.

Authors:  Philip T Yanos; Weli Lu; Shula Minsky; Gerard L Kiely
Journal:  Psychiatr Serv       Date:  2004-01       Impact factor: 3.084

View more
  5 in total

1.  Twelve-Month Health Care Use and Mortality in Commercially Insured Young People With Incident Psychosis in the United States.

Authors:  Michael Schoenbaum; Jason M Sutherland; Andre Chappel; Susan Azrin; Amy B Goldstein; Agnes Rupp; Robert K Heinssen
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

Review 2.  Is early intervention for psychosis feasible and effective?

Authors:  Vinod H Srihari; Jai Shah; Matcheri S Keshavan
Journal:  Psychiatr Clin North Am       Date:  2012-07-21

3.  Insurance Status and Continuity for Young Adults With First-Episode Psychosis.

Authors:  Ezra Golberstein; Susan H Busch; Kyaw Sint; Robert A Rosenheck
Journal:  Psychiatr Serv       Date:  2021-05-11       Impact factor: 4.157

4.  Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study.

Authors:  Vinod H Srihari; Cenk Tek; Jessica Pollard; Suzannah Zimmet; Jane Keat; John D Cahill; Suat Kucukgoncu; Barbara C Walsh; Fangyong Li; Ralitza Gueorguieva; Nina Levine; Raquelle I Mesholam-Gately; Michelle Friedman-Yakoobian; Larry J Seidman; Matcheri S Keshavan; Thomas H McGlashan; Scott W Woods
Journal:  BMC Psychiatry       Date:  2014-12-04       Impact factor: 3.630

Review 5.  A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States.

Authors:  Wenjie Zhang; Tony B Amos; Stephen W Gutkin; Nicole Lodowski; Emma Giegerich; Kruti Joshi
Journal:  Clinicoecon Outcomes Res       Date:  2018-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.